1-8 of 8
Jonathan D. Powell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning

Shannon R. McCurdy, Vedran Radojcic, Hua-Ling Tsai, Ante Vulic, Elizabeth Thompson, Sanja Ivcevic, Christopher G. Kanakry, Jonathan D. Powell, Brian Lohman, Djamilatou Adom, Sophie Paczesny, Kenneth R. Cooke, Richard J. Jones, Ravi Varadhan, Heather J. Symons, Leo Luznik
Journal: Blood
Blood (2022) 139 (4): 608–623.
https://doi.org/10.1182/blood.2021013054
Published: 2022
Includes: Supplemental data
Journal Articles

Nonmyeloablative (NMA), HLA-Mismatched Unrelated Donor (mMUD) BMT with High-Dose Posttransplantation Cyclophosphamide (PTCy) Has Outcomes Similar to Matched BMT

Yvette L. Kasamon, Ephraim J. Fuchs, Javier Bolaños-Meade, Mary S. Leffell, Marianna Zahurak, Gary L. Rosner, Jonathan D. Powell, Richard F. Ambinder, Richard J. Jones, Leo Luznik
Journal: Blood
Blood (2015) 126 (23): 2002.
https://doi.org/10.1182/blood.V126.23.2002.2002
Published: 2015
Journal Articles

Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS

Christopher G. Kanakry, Hua-Ling Tsai, Javier Bolaños-Meade, B. Douglas Smith, Ivana Gojo, Jennifer A. Kanakry, Yvette L. Kasamon, Douglas E. Gladstone, William Matsui, Ivan Borrello, Carol Ann Huff, Lode J. Swinnen, Jonathan D. Powell, Keith W. Pratz, Amy E. DeZern, Margaret M. Showel, Michael A. McDevitt, Robert A. Brodsky, Mark J. Levis, Richard F. Ambinder, Ephraim J. Fuchs, Gary L. Rosner, Richard J. Jones, Leo Luznik
Journal: Blood
Blood (2014) 124 (25): 3817–3827.
https://doi.org/10.1182/blood-2014-07-587477
Published: 2014
Includes: Supplemental data
Journal Articles

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

Clinical Trials & Observations
Leo Luznik, Javier Bolaños-Meade, Marianna Zahurak, Allen R. Chen, B. Douglas Smith, Robert Brodsky, Carol Ann Huff, Ivan Borrello, William Matsui, Jonathan D. Powell, Yvette Kasamon, Steven N. Goodman, Allan Hess, Hyam I. Levitsky, Richard F. Ambinder, Richard J. Jones, Ephraim J. Fuchs
Journal: Blood
Blood (2010) 115 (16): 3224–3230.
https://doi.org/10.1182/blood-2009-11-251595
Published: 2010
Journal Articles

A 2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells

Paul E. Zarek, Ching-Tai Huang, Eric R. Lutz, Jeanne Kowalski, Maureen R. Horton, Joel Linden, Charles G. Drake, Jonathan D. Powell
Journal: Blood
Blood (2008) 111 (1): 251–259.
https://doi.org/10.1182/blood-2007-03-081646
Published: 2008
Includes: Supplemental data
Journal Articles

Bringing IL-2 down to earth

Jonathan D. Powell
Journal: Blood
Blood (2007) 109 (7): 2671–2672.
https://doi.org/10.1182/blood-2007-01-067017
Published: 2007
Journal Articles

Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse

Nadira Durakovic, Vedran Radojcic, Mario Skarica, Karl B. Bezak, Jonathan D. Powell, Ephraim J. Fuchs, Leo Luznik
Journal: Blood
Blood (2007) 109 (10): 4564–4574.
https://doi.org/10.1182/blood-2006-09-048124
Published: 2007
Includes: Supplemental data
Journal Articles

A Novel Allogeneic Transplant Conditioning Regimen Designed for Tolerance Induction in Patients with Severe Sickle Cell Disease.

Elizabeth M. Kang, MD, Matthew Hsieh, MD, Jonathan D. Powell, MD/PhD, Beth Link, RN, Theresa Donohue, PA, Gregory Kato, MD, Robert Machado, MD, Mark Gladwin, MD, Griffin Rodgers, MD, John F. Tisdale, MD
Journal: Blood
Blood (2005) 106 (11): 5429.
https://doi.org/10.1182/blood.V106.11.5429.5429
Published: 2005